Le Lézard
Classified in: Health, Science and technology
Subject: FEA

It's time for people to take control of their own health data, says Tento Applied Sciences


LONDON, June 15, 2021 /PRNewswire/ -- The contentious issue of precisely who owns, controls and shares people's most personal health and private data has been brought to the fore by the recent #NHSdatagrab debate. According to Mark Shaw, CEO of Tento Applied Sciences, now is the time for people to gain a greater degree of custodianship, responsibility and understanding of their personal data and how it is used.

The UK Government's General Practice Data for Planning and Research (GPDPR) scheme, which will allow NHS Digital to extract sensitive patient data from GP surgeries in England for research and analysis purposes, is proving highly contentious.

"The GPDPR scheme may well have been pushed back to September, but now is still the ideal time for all of us to take more interest in who can access our medical and personal records. The level of outrage amongst large sections of the British public was significant, with many expressing frustration at the lack of transparency and how little they knew about the plan," stated Shaw.

"Adequately anonymised medical data is essential in helping health authorities develop treatments and plan for health emergencies. However, the real problem here is the lack of clarity about how the NHS will safeguard patient data, and exactly which third parties will be able to access it.

"Despite NHS Digital assuring the British public that they 'do not allow data to be used solely for commercial purposes', many critics remain unconvinced. Moreover, the fact that patients still need to opt out of this data-sharing plan (rather than opt in) has done little to assuage public opposition.

"Cybersecurity experts also have concerns. Even though the NHS Digital plan is to use 'pseudonymised' patient data, excluding any personally identifiable information (other than postcodes, in a coded form), there is still a serious danger of a cybersecurity breach. This is one reason why the British Medical Association has called for the scheme to be delayed 'until patients and the public have had time to understand the programme and choose to opt out if they wish'.

"The most positive aspect of the #NHSdatagrab debate is that it shines a light on these issues. We firmly believe that individuals should have complete self-sovereignty over their medical data and all other important certifications that we need to live and exist in our increasingly digitised world.

"Giving individuals the freedom to access their documents and certificates in a simple, highly secure, digitised manner is the first step. The second step is granting governments, healthcare organisations and pharmaceutical companies access to the fully anonymised data they need for their critical tests and trials.

"It's high time that we all took back control of our own data. In no circumstances should our medical information be shared, without restriction, to be monetised by big businesses: gaining a deeper understanding of how the GPDPR scheme works is essential. This is why our mission is to enable every person on the planet to own and control their medical and personal data, and to empower organisations and governments to put individuals first."

For further information, go to the Tento Applied Sciences website at www.tentoas.com  

About Tento Applied Sciences

Tento Applied Sciences is a global data systems company supplying digital identity and document management solutions to businesses and consumers.

They have developed a data systems platform called Tento Link that verifies personal identity, automates data management processes, distributes verified digital health documents, and provides automated data reporting solutions.

The Tento platform is a pioneering solution designed to drive standards of excellence for employers, communities, laboratories, and Governments.

It comprises three components:

Tento Link ? a connected data platform for managing, verifying and issuing digital documents, medical tests and data between approved stakeholders.

Tento Wallet ? a permission-based digital wallet that uses AES-256 security that enables people to store and share personal details, including health tests, government IDs, work passes, tickets and more, in a decentralised manner.

Tento Authenticator ? An application that enables organisations to determine entry conditions, verify credentials for employees/customers, and acts as an access control through contactless scanning and verification of identity.

The platform is creating a hugely positive network of groups across different sectors united in shared goals ? creating efficient processes that simplify tasks and digitise business operations.

 

SOURCE Tento Applied Sciences


These press releases may also interest you

at 17:32
Pye-Barker Fire & Safety ? the largest fully integrated and full-service fire protection, life safety and security services provider in the United States ? has acquired ADS Systems with the goal of providing security and fire alarm solutions to more...

at 17:30
UpGuard, esteemed for its innovative Third-Party and Supplier Risk Management solutions and ranked #1 by G2 for seven consecutive quarters, was recognized today as one of the Australian Financial Review BOSS's Best Places to Work in Technology. This...

at 17:21
Genpact Limited , a global professional services and solutions firm delivering outcomes that shape the future, today announced that its board of directors has declared a cash dividend of $0.1525 per common share for the second quarter of 2024. The...

at 17:20
RSA, the security-first identity leader, announced that it is bolstering Microsoft environments through a continuing partnership that brings additional security to Office environments. The new External Authentication Methods (EAM) feature will allow...

at 17:00
Descartes Systems Group , the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report its first quarter fiscal 2025 financial results after market close on Wednesday, May 29, 2024. Members of Descartes' executive...

at 17:00
The KLA Corporation Board of Directors today declared a quarterly cash dividend of $1.45 per share on its common stock, payable on May 31, 2024 to KLA shareholders of record as of the close of business on May 15, 2024....



News published on and distributed by: